5-methylsulfonylamino-6-phenoxy-1-indanone has been researched along with Adjuvant Arthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böttcher, I; Grüninger, M; Jagher, B; Rordorf-Adam, C | 1 |
| Hirschelmann, R; Schade, R | 1 |
| Böttcher, I; Glatt, M; Schweizer, A; Werner, H | 1 |
3 other study(ies) available for 5-methylsulfonylamino-6-phenoxy-1-indanone and Adjuvant Arthritis
| Article | Year |
|---|---|
The anti-inflammatory pharmacologic profile of CGP 28237 (5-methylsulfonylamino-6-phenoxy-1-indanone).
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Autoimmune Diseases; Digestive System; Female; Indans; Indenes; Male; Mice; Rats | 1987 |
6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Indans; Indenes; Inflammation; Isoxazoles; Leflunomide; Oxazoles; Rats; Sulfanilamides | 1988 |
A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Arthritis, Experimental; Drug Tolerance; Edema; Female; Fever; Indans; Indenes; Male; Mice; Mice, Inbred Strains; Occult Blood; Pulmonary Embolism; Rabbits; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Stomach Ulcer | 1987 |